# Cellbox Labs

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cellbox-labs

- Industry: Software
- Headquarters: Riga, Latvia
- Website: https://www.cellboxlabs.com
- Total disclosed funding: $3.8M
- Latest round: Seed (Jan 27, 2026)
- Investors on record: 2

## About

Based in Riga, Latvia, and founded in 2020 by Arturs Abols, Gatis Mozolevskis, and Roberts Rimša, Cellbox Labs operates as a medical software company that offers technology solutions for drug discovery and development at scale. In January 2026, Cellbox Labs LTD raised EUR 3.23 million in seed funding Buildit Accelerator, ASP Asset Management and Latvian Business Angel. The firm offers a PDMS-free gut-on-chip platform designed for anaerobic conditions necessary for microbiota cultivation, using integrated biosensors and a cultivation system. This technology is optimized for low molecule absorption, making it suitable for drug testing and compatible with mass manufacturing methods. Additionally, Cellbox Labs offers a medical device that operates the chips autonomously, featuring top and bottom channel microscopy and an AI-driven flow adjustment system for advanced protocol execution. The company plans to use the August 2025 funding to accelerate the development of its platform.

## Funding rounds

- Seed, Jan 27, 2026, $3.8M — Buildit Accelerator, ASP Asset Management AIFP

## Investors

- Buildit Accelerator (https://capitalatlas.ai/funds/buildit-accelerator) — Seed
- ASP Asset Management AIFP — Seed